Immunotherapies influence the influenza vaccination response in multiple sclerosis patients: an explorative study

Teriflunomide effect on immune response to influenza vaccine in patients with multiple sclerosis

(2013) A. Bar-Or et al.   NEUROLOGY

H1N1 Antibody Persistence 1 Year After Immunization With an Adjuvanted or Whole-Virion Pandemic Vaccine and Immunogenicity and Reactogenicity of Subsequent Seasonal Influenza Vaccine: A Multicenter Follow-on Study

(2012) Woolf T. Walker et al.   CLINICAL INFECTIOUS DISEASES

A(H1N1)pdm09 Vaccination of Health Care Workers: Improved Immune Responses in Low Responders Following Revaccination

(2012) Rishi Delan Pathirana et al.   JOURNAL OF INFECTIOUS DISEASES

Humoral immune response to influenza vaccine in natalizumab-treated MS patients

(2012) Mattias Vågberg et al.   NEUROLOGICAL RESEARCH

Relapse risk in patients with multiple sclerosis after H1N1 vaccination, with or without seasonal influenza vaccination

(2011) Nuala McNicholas et al.   JOURNAL OF NEUROLOGY

Seasonal and H1N1v influenza vaccines in MS: Safety and compliance

(2011) Eitan Auriel et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Temporal relationship between environmental influenza A and Epstein–Barr viral infections and high multiple sclerosis relapse occurrence

(2011) Mervi Oikonen et al.   Multiple Sclerosis Journal

Antigen-specific adaptive immune responses in fingolimod-treated multiple sclerosis patients

(2010) Matthias Mehling et al.   ANNALS OF NEUROLOGY